Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina.
JACC Heart Fail. 2013 Jun;1(3):245-51. doi: 10.1016/j.jchf.2013.01.008. Epub 2013 Jun 3.
The study sought to derive and validate risk-prediction tools from a large nationwide registry linked with Medicare claims data.
Few clinical models have been developed utilizing data elements readily available in electronic health records (EHRs) to facilitate "real-time" risk estimation.
Heart failure (HF) patients ≥ 65 years of age hospitalized in the GWTG-HF (Get With The Guidelines-Heart Failure) program were linked with Medicare claims from January 2005 to December 2009. Multivariable models were developed for 30-day mortality after admission, 30-day rehospitalization after discharge, and 30-day mortality/rehospitalization after discharge. Candidate variables were selected based on availability in EHRs and prognostic value. The models were validated in a 30% random sample and separately in patients with reduced and preserved ejection fraction (EF).
Among 33,349 patients at 160 hospitals, 3,002 (9.1%) died within 30 days of admission, 7,020 (22.8%) were rehospitalized within 30 days of discharge, and 8,374 (27.2%) died or were rehospitalized within 30 days of discharge. Compared with patients classified as low risk, high-risk patients had significantly higher odds of death (odds ratio [OR]: 8.82, 95% confidence interval [CI]: 7.58 to 10.26), rehospitalization (OR: 1.99, 95% CI: 1.86 to 2.13), and death/rehospitalization (OR: 2.65, 95% CI: 2.44 to 2.89). The 30-day mortality model demonstrated good discrimination (c-index 0.75) while the rehospitalization and death/rehospitalization models demonstrated more modest discrimination (c-indices of 0.59 and 0.62), with similar performance in the validation cohort and for patients with preserved and reduced EF.
These predictive models allow for risk stratification of 30-day outcomes for patients hospitalized with HF and may provide a validated, point-of-care tool for clinical decision making.
本研究旨在从与医疗保险索赔数据相关联的大型全国性注册处中提取和验证风险预测工具。
很少有临床模型是利用电子健康记录(EHR)中易于获得的数据元素开发的,以促进“实时”风险评估。
将年龄≥65 岁的心力衰竭(HF)患者纳入 GWTG-HF(遵循指南-心力衰竭)计划中的住院患者,并与 2005 年 1 月至 2009 年 12 月的医疗保险索赔进行关联。对入院后 30 天死亡率、出院后 30 天再入院率和出院后 30 天死亡率/再入院率进行多变量模型构建。候选变量基于 EHR 中的可用性和预后价值进行选择。在 30%的随机样本中对模型进行验证,并分别在射血分数降低和保留的患者中进行验证。
在 160 家医院的 33349 名患者中,3002 名(9.1%)在入院后 30 天内死亡,7020 名(22.8%)在出院后 30 天内再次入院,8374 名(27.2%)在出院后 30 天内死亡或再次入院。与低危患者相比,高危患者的死亡(优势比[OR]:8.82,95%置信区间[CI]:7.58 至 10.26)、再入院(OR:1.99,95%CI:1.86 至 2.13)和死亡/再入院(OR:2.65,95%CI:2.44 至 2.89)的可能性显著更高。30 天死亡率模型具有良好的区分度(c 指数 0.75),而再入院和死亡/再入院模型的区分度则稍差(c 指数分别为 0.59 和 0.62),在验证队列和射血分数保留和降低的患者中具有相似的性能。
这些预测模型可对因 HF 住院的患者进行 30 天结局的风险分层,并可能为临床决策提供一种经过验证的、即时可用的工具。